-
Publication of a new decree related to the law n°2011-2012 of 29 December 2011 improving the safety of medicines and health products ('Transparency law')
23 May 2013
Publication
The long-awaited decree was issued on 21 May 2013 (the "Decree"). The Decree enables the implementation of the Transparency Law.
A circular which will provide complete terms and conditions of application of the Decree should also be published...
-
China Publishes Revised Good Supply Practice (GSP) Standards for Pharmaceutical Products
20 May 2013
Publication
After several years of drafting and three rounds of public consultation, the Ministry of Health has at last published the revised Good Supply Practice for Pharmaceutical Products (Revised GSP Standards) (药品经营质量管理规范) on 22 January 2013. The Revised GSP Standards...
-
Clifford Chance advised Bayer on the acquisition of Steigerwald Arzneimittelwerk GmbH
17 May 2013
News
Clifford Chance advised Bayer on the acquisition of Steigerwald Arzneimittelwerk GmbH ("Steigerwald"), Darmstadt. The acquisition is a strategic move for strengthening Bayer's Consumer Care division which specializes in marketing OTC medicinal products. The transaction...
-
Foreign investment regulation in Australia
16 May 2013
Publication
Australia continues to be the destination of a significant volume of foreign direct investment, and has been ranked within the top 10 most attractive locations for foreign investment globally.
Foreign investment in Australia is governed by a complex combination...
-
Another step towards a unitary European patent
12 April 2013
Publication
The Unitary patent package
Twenty-five member states of the European Union, including the Czech Republic and Slovakia recently signed an Agreement on a Unified Patent Court ("UPC"). The agreement (if ratified by the required number of participating...
-
Clifford Chance advises Nabtesco on acquisition of Italian door system manufacturer
2 April 2013
News
Tokyo, Milan: Leading international law firm Clifford Chance has advised Nabtesco Corporation, a Japanese company listed on the Tokyo Stock Exchange, on its purchase of OCLAP S.R.L., an Italian door system manufacturer. The deal signed on 28 March 2013.
Andrew...
-
Verhalten bei Ermittlungen der Europäischen Kommission oder des Bundeskartellamtes
20 March 2013
Publication
Allgemeine Vorbereitung Die folgenden Maßnahmen sollten zur allgemeinen Vorbereitung für den Fall einer Vor-Ort-Nachprüfung oder Durchsuchung durch Kartellbehörden getroffen werden:
1. Erstellen Sie eine Liste der Mitglieder der Geschäftsleitung...
-
New Australian pharmaceutical code increases reporting - with more to come
14 March 2013
Publication
On 20 December 2012, the Australian Competition and Consumer Commission (ACCC) authorised edition 17 of Medicines Australia’s Code of Conduct (MACC) for two years only. Medicines Australia had sought authorisation for five years.
The MACC is a voluntary...
-
Clifford Chance advises Pfizer on the IPO of its former Animal Health business ZOETIS
7 February 2013
News
Clifford Chance advised Pfizer on the IPO of its former Animal Health business ZOETIS. With the IPO, Pfizer has created the world's largest standalone company fully devoted to animal health medicines and vaccines.
ZOETIS' has more than 9,500 employees and its...
-
Newsletter - Patent Law Series 'EU patent - almost there?'
24 January 2013
Publication
After years of deliberations, the so-called "EU package" was approved by the European Parliament and Council in December 2012. While it remains to be seen whether the legislative acts of the highly contentious package will really come into force as...